- CA$6.47m
- CA$5.80m
- CA$2.19m
- 53
- 43
- 42
- 43
Annual income statement for Innovotech, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.19 | 1.48 | 1.13 | 1.18 | 2.19 |
Cost of Revenue | |||||
Gross Profit | 0.867 | 1.12 | 0.78 | 0.812 | 1.11 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.08 | 1.13 | 1.27 | 1.46 | 2.15 |
Operating Profit | 0.109 | 0.354 | -0.14 | -0.278 | 0.048 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 0.106 | 0.367 | -0.137 | -0.158 | 0.215 |
Net Income After Taxes | 0.106 | 0.367 | -0.137 | -0.158 | 0.215 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 0.106 | 0.367 | -0.137 | -0.158 | 0.225 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.106 | 0.367 | -0.137 | -0.158 | 0.225 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.001 | 0.007 | -0.004 | -0.004 | 0.005 |